Coletiva do lançamento do Plano Nacional de operacionalização da vacina contra a COVID-19
Date:
16/12/2020
Durante o lançamento do Plano Nacional de Operacionalização da Vacina contra a Covid-19, na manhã desta quarta-feira (16/12), o ministro da Saúde, Eduardo Pazuello, reforçou o compromisso do Governo Federal em incorporar todas as vacinas contra o coronavírus que obtiverem o aval da Agência Nacional de Vigilância Sanitária (Anvisa). “Todas as vacinas produzidas no Brasil, ou pelo Butant...
See more details
Betacoronavirus/immunology, Coronavirus Infections/prevention & control, Pneumonia, Viral/prevention & control, Pandemics/prevention & control, Viral Vaccines/supply & distribution, Immunization Programs/organization & administration, Brazil/epidemiology, Risk Groups, Brazilian Health Surveillance Agency, Social Isolation, Masks, Clinical Trial, Phase III, Mobile Applications, Health Promotion, Local Health Systems/organization & administration, COVID-19, Pazuello, Eduardo, Astrazeneca, Vacina de Oxford, Fiocruz, Instituto Butantan, Sinovac Biotech, Coronavac
I Seminário Nacional do Conass e Conasems - 09/12/2020
Date:
09/12/2020
As inscrições para o I Seminário Conass e Conasems encerram amanhã (terça-feira, 08), às 18h.
O impacto da pandemia de Covid-19 nos serviços de saúde e a resposta do SUS serão os principais temas abordados no I Seminário Nacional do Conass e Conasems. O evento, que será realizado de forma virtual, ocorrerá entre os dias 9 e 11 de dezembro, sempre entre 14h30 e 18h.
As experiências be...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/prevention & control, Chronic Disease/prevention & control, Betacoronavirus/immunology, Pneumonia, Viral/prevention & control, Coronavirus Infections/prevention & control, Viral Vaccines/supply & distribution, Health Councils/organization & administration, Unified Health System/organization & administration, Congress, Brazil/epidemiology, Public Health Systems, Elective Surgical Procedures, Social Isolation, Masks, Financial Resources in Health/economics, Primary Health Care/organization & administration, Personal Protective Equipment/supply & distribution, Noncommunicable Diseases/prevention & control, Health Personnel/organization & administration, Hospital Administration, Equity in Access to Health Services, Telemedicine, Health Management, Pandemics/statistics & numerical data, Polymerase Chain Reaction/statistics & numerical data, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, Governmental Research Institutes, Clinical Trial, Phase III, Healthy Volunteers, Brazilian Health Surveillance Agency, Immunization Programs/organization & administration, Vaccine Potency, COVID-19, Pazuello, Eduardo , Coronavac, Instituto Butantan, Sinovac Biotech, Pfizer, Astrazeneca, Fiocruz, Vacina de Oxford
Ministério da Saúde apresenta balanço do combate à COVID-19
Date:
27/11/2020
Siga o Ministério da Saúde
http://www.twitter.com/minsaude
http://www.facebook.com/minsaude
http://www.instagram.com/minsaude
https://www.linkedin.com/company/mini...
See more details
Coronavirus Infections/epidemiology, Pneumonia, Viral/epidemiology, Pandemics/statistics & numerical data, Financial Resources in Health/economics, Health Systems/economics, Brazil/epidemiology, Access to Essential Medicines and Health Technologies, Ventilators, Mechanical/supply & distribution, Hospital Bed Capacity/statistics & numerical data, Intensive Care Units/statistics & numerical data, Epidemiological Monitoring, Coronavirus Infections/diagnosis, Pneumonia, Viral/diagnosis, Polymerase Chain Reaction/statistics & numerical data, Enzyme-Linked Immunosorbent Assay/statistics & numerical data, Suicide/prevention & control, Central Nervous System Agents/supply & distribution, Social Isolation/psychology, Health Information Management, Computer Security, Betacoronavirus/immunology, Coronavirus Infections/immunology, Pneumonia, Viral/immunology, Viral Vaccines/immunology, Brazilian Health Surveillance Agency, Immunization Programs/organization & administration, Risk Groups, COVID-19